RJA
KTOVW

Raymond James & Associates’s Kitov Pharma Ltd. Warrants KTOVW Stock Holding History

Raymond James & Associates’s Portfolio KTOVW Stock Details KTOVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-14,500
Closed -$16K – 3400
2016
Q3 		$16K Buy
+14,500
New +$11.8K ﹤0.01% 3148

Other funds holding KTOVW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Raymond James & Associates's KTOVW Position: Q4 2016 in Review

Raymond James & Associates sold out of Kitov Pharma Ltd. Warrants (KTOVW) in Q4 2016, closing a stake of 14,500 shares — an estimated $16K sold.

Raymond James & Associates first reported a position in KTOVW in Q3 2016 and held it in 1 quarter. The position peaked at $16K in Q3 2016. 3 funds tracked by Wall St. Rank hold KTOVW as of Q4 2016.

  • Raymond James & Associates reported no remaining Kitov Pharma Ltd. Warrants position as of Q4 2016 after selling out during the quarter.
  • Raymond James & Associates sold 14,500 Kitov Pharma Ltd. Warrants shares in Q4 2016, an estimated $16K.
  • Raymond James & Associates first reported a position in Kitov Pharma Ltd. Warrants in Q3 2016 and held it in 1 quarter.
  • Raymond James & Associates's Kitov Pharma Ltd. Warrants position peaked at $16K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Kitov Pharma Ltd. Warrants as of Q4 2016.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.